Navigation Links
Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science'
Date:4/7/2008

- Roundtable to examine the crisis in science education, scientific

research, and the role science should play in the 2008 Presidential

Election -

NEW YORK, April 7, 2008 /PRNewswire/ -- Since its launch in October 2006, the Charlie Rose Science Series has explored some of the most complex science and human health issues facing the 21st century, including the brain, the human genome, HIV/AIDS, diseases of the mind, stem cells and global health. The series has featured interviews with Nobel Laureates and other great minds in science who have provided valuable insights into new advances and breakthroughs in human health research.

In the final installment, Charlie Rose and co-host Sir Paul Nurse, Nobel laureate and president of Rockefeller University, will focus on "The Imperative and Promise of Science." This panel will explore the roles of science in our society and its impact on our lives. The roundtable discussion will address the potential crisis in science education, scientific innovation, and the role science should play in the 2008 Presidential Election. It will feature scientific leaders who have inspired a new generation of thinkers.

The Charlie Rose Science Series, Episode 13, which is sponsored by Pfizer Inc, will begin airing on April 7, 2008 on more than 200 PBS stations across the country.

"Throughout our science series, I hope we have stimulated our audience's curiosity about science and communicated an understanding of how dramatic our age of discovery is," said Charlie Rose. "Science affects nearly every aspect of our lives. It is a tool for solving problems, both large and small, that enriches our society through discovery and understanding."

Charlie's distinguished guests for the final episode are: Harold Varmus, MD, 1989 Nobel Laureate in Medicine or Physiology and President/CEO, Memorial Sloan-Kettering Cancer Center; Shirley Ann Jackson, Ph.D., President, Rensselaer Polytechnic Institute; Lisa Randall, Ph.D., Professor of Physics, Harvard University; and, Bruce Alberts, Ph.D., Past President, National Academy of Sciences, Biochemist, University of California at San Francisco, and Editor-in-Chief of Science Magazine.

Science continues to hold the key to many of the fascinating aspects of humanity. From dinosaurs to space travel, mankind's ability to discover and fully explore natural phenomena is a direct result of scientific innovation and understanding.

The countless scientific achievements made in the 20th century have enriched the world. Experts have called this century an age of science -- life expectancy nearly doubled; biology helped discover how humans, plants and animals came to be on this planet; the great achievements in physics, quantum mechanics, and relativity have transformed the way that people view the universe.

"Science is the most reliable way we have of gaining knowledge about the world," noted Dr. Nurse. "With that knowledge, we can improve our standard of living, improve our health, create new industries, and protect our environment. Providing information about science through accessible programs like Charlie Rose is a good step in this process. I am delighted to have been involved with this effort and am pleased that Pfizer promoted and supported the Science Series."

"As one of the global leaders that conducts cutting edge research to develop new medicines, we understand the importance of cultivating the next generation of scientists who can build on the science that has resulted to date," said Joseph P. Hammang, Ph.D., Senior Director, Science Policy and Public Affairs-Pfizer Global Research and Development. "At Pfizer, we recognize our responsibility to develop and nurture scientific innovation and research. We believe our Charlie Rose Science Series has fostered a positive public dialogue on science that will lead to increased interest in the importance of continued investment in scientific discovery."

Pfizer's support for the Charlie Rose Science Series and its exploration of advances in scientific research, their contribution to our understanding of the world around us, and how these breakthroughs may be applied to improving human health is part of Pfizer's commitment to expanding scientific understanding.

"Pfizer's recognition of the importance and relevance of science to our daily lives is crucial in the efforts to engage the public in the scientific process," said Charlie Rose. "Through its support the past year, we were able to bring the wonders of science to our audience. We hope that the company's commitment to exploring science will continue to lead to groundbreaking discoveries and attract a new generation of scientists."

Past episodes of the Charlie Rose Science Series have explored research that has led to a better understanding of the human brain; the discovery and mapping of human DNA; new insights into longevity and the body's aging mechanisms; an in-depth look at cancer, the latest advances in stem cell research; the problem of obesity in the American population, especially among children and teenagers; the continually growing problem of HIV/AIDS worldwide; the prevention, treatment, and global understanding of cardiovascular disease; emerging threats to global health and the search for effective treatments for diseases of the developing world; human sexuality and sexual health; and diseases of the brain.

For more information about the Charlie Rose Science Series or to watch clips from past episodes, please visit http://www.charlierose.com or http://www.pfizer.com/scienceseries.


'/>"/>
SOURCE Charlie Rose
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Final Episode of Charlie Rose Science Series Set to Air Monday, April 7th
2. Crdentia Appoints Charlie Mayhone to Director of Operations for its National Travel Division and Charlotte, North Carolina Market
3. American Society of Transplantation Applauds Rep. Inslee for His Efforts to Pass the Charlie W. Norwood Living Organ Donation Act
4. Charlie Rose Science Series
5. Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World
6. Charlie Rose Science Series Episode #10 - GLOBAL HEALTH October 29, 2007
7. Charlie Rose Science Series Explores Heart Disease
8. California Science Center Welcomes 1-Millionth BODY WORLDS Visitor
9. Neuroscience Peer Review Consortium announces increased journal participation
10. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
11. Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... ... Braun Industries will be participating as an exhibitor at EMS Today 2017. ... 23-25, 2017 at the Calvin L. Rampton Salt Palace Convention Center in Salt Lake ... on display. , “JEMS is a leader in EMS news and education. ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... in better care, and MEDfx and the Delaware Health Information Network (DHIN) have ... As the nation’s first state-wide health information exchange, DHIN stores and shares real-time ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Axendia, **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 ... regulatory burden? Pay dividends in enhanced and predictable product performance? Streamline processes ...
(Date:2/18/2017)... ... 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing ... Ken was impressed with the safety and reliability of the Stannah Stairlift as ... show. This endorsement by Ken Matthews can be heard on News Radio WHP ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... Research and Markets has announced the addition of ... report to their offering. ... Traditional medical devices include devices (e.g., ... implantables, large endoscopes, needle based drug delivery, lab based diagnostics ... to three decades for the treatment and management of various ...
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
Breaking Medicine Technology: